[5-(6-Aminopurin-9-yl)-3,4-dihydroxy-2-oxolanyl]methyl phosphate

BGC Id:	115866999641
CAS No:	29984-33-6
Synonyms:	vidarabine phosphate ; vidarabinemonophosphate ; arabinosyladeninemonophosphate ; adeninearabinosidemonophosphate ; 5'-arabinosyladeninemonophosphate ; ara-a ; vidarabine monophasphate ; ara-amp ; vidarabine-5'-monophosphate ; cl-808
Molecular Formula:	C10H14N5O7P
Molecular Weight:	347.22
EINECS:	249-990-8

What other providers are available for CAS 29984-33-6?

Identify

Synonyms:

vidarabine phosphate ; vidarabinemonophosphate ; arabinosyladeninemonophosphate ; adeninearabinosidemonophosphate ; 5'-arabinosyladeninemonophosphate ; ara-a ; vidarabine monophasphate ; ara-amp ; vidarabine-5'-monophosphate ; cl-808

CAS:

29984-33-6

EINECS:

249-990-8

Molecular Formula:

C10H14N5O7P

MDL:

Properties

Molecular Weight:

347.22 g·mol−1

Melting point:

213 °C

Physical Description:

crystalline

Safety Information

Hazard Symbols: Xn, T, Xi

Europe standard Hazard pictograms, code and definition

Hazard Classes:

6.1(a)

Hazardous Substances Data:

Non-Regulated Material ¹

Risk Codes:

20/22-40-23/24/25-36/37/38 (R)

Safety Codes:

37/39-24/25-45-36/37/39-22-36-26 (S)

RID / ADR:

2811

RTECS:

AU6204000

Storage temperature:

Store at 0 °C

What other providers are available for CAS 29984-33-6?

In addition to the providers presented here for [5-(6-Aminopurin-9-yl)-3,4-dihydroxy-2-oxolanyl]methyl phosphate with the CAS number 29984-33-6, there are other 47 providers with slightly different product names available for this CAS number.

Vidarabine monophosphate

Arabinofuranosyladenine monophosphate

+3 additional providers that we know from the past

9-beta-D-Arabinofuranosyl-adenine-5'-monophosphate

+2 additional providers that we know from the past

Adenine-9-beta-D-arabinofuranoside-5'-monophosphate

BuGuCh & Partners +13 additional providers that we know from the past

9-(5-O-Phosphono-b-D-arabinofuranosyl)-9H-purin-6-amine

Hangzhou Zhongqi Chem Co., Ltd | Shandong SanYoung Industry Co., Ltd +5 additional providers that we know from the past